Publikationen von Michael W. Sereda

Ekins, S.; Litterman, N. K.; Arnold, R. J. G.; Burgess, R. W.; Freundlich, J. S.; Gray, S. J.; Higgins, J. J.; Langley, B.; Willis, D. E.; Notterpek, L. et al.; Pleasure, D.; Sereda, M. W.; Moore, A.: A brief review of recent Charcot-Marie-Tooth research and priorities. Faculty of 1000 Research 4, 53 (2015)

Chumakov, I.; Milet, A.; Cholet, N.; Primas, G.; Boucard, A.; Pereira, Y.; Graudens, E.; Mandel, J.; Laffaire, J.; Foucquier, J. et al.; Glibert, F.; Bertrand, V.; Nave, K.-A.; Sereda, M. W.; Vial, E.; Guedj, M.; Hajj, R.; Nabirotchkin, S.; Cohen, D.: Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases 9 (1), 201 (2014)

Mannil, M.; Solari, A.; Leha, A.; Pelayo-Negro, A. L.; Berciano, J.; Schlotter-Weigel, B.; Walter, M. C.; Rautenstrauss, B.; Schnizer, T. J.; Schenone, A. et al.; Seeman, P.; Kadian, C.; Schreiber, O.; Angarita, N. G.; Fabrizi, G. M.; Gemignani, F.; Padua, L.; Santoro, L.; Quattrone, A.; Vita, G.; Calabrese, D.; CMT-TRIAAL/CMT-TRAUK Group; Young, P.; Laurà, M.; Haberlová, J.; Mazanec, R.; Paulus, W.; Beissbarth, T.; Shy, M. E.; Reilly, M. M.; Pareyson, D.; Sereda, M. W.: Selected items from the Charcot-Marie-Tooth (CMT) neuropathy score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients. Neuromuscular Disorders 24 (11), S. 1003 - 1017 (2014)

Avenali, L.; Narayanan, P.; Rouwette, T.; Cervellini, I.; Sereda, M.; Gomez-Varela, D.; Schmidt, M.: Annexin A2 regulates TRPA1-dependent nociception. Journal of Neuroscience 34 (44), S. 14506 - 14516 (2014)

Fledrich, R.; Stassart, R. M.; Klink, A.; Rasch, L. M.; Prukop, T.; Haag, L.; Czesnik, D.; Kungl, T.; Abdelaal, T. A. M.; Keric, N. et al.; Stadelmann, C.; Brück, W.; Nave, K.-A.; Sereda, M. W.: Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine 20 (9), S. 1055 - 1061 (2014)

Prukop, T.; Epplen, D. B.; Nientiedt, T.; Wichert, S. P.; Fledrich, R.; Stassart, R. M.; Rossner, M. J.; Edgar, J. M.; Werner, H. B.; Nave, K.-A. et al.; Sereda, M. W.: Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. The American Journal of Human Genetics 94 (4), S. 533 - 546 (2014)

Tönges, L.; Günther, R.; Suhr, M.; Jansen, J.; Balck, A.; Saal, K.-A.; Barski, E.; Nientied, T.; Götz, A. A.; Koch, J.-C. et al.; Mueller, B. K.; Weishaupt, J. H.; Sereda, M. W.; Hanisch, U.-K.; Bähr, M.; Lingor, P.: Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia 62 (2), S. 217 - 232 (2014)

Stassart, R. M.; Fledrich, R.; Velanac, V.; Brinkmann, B. G.; Schwab, M. H.; Meijer, D.; Sereda, M. W.; Nave, K.-A.: A role for Schwann cell-derived neuregulin-1 in remyelination. Nature Neuroscience 16 (1), S. 48 - 54 (2013)

Fledrich, R.; Stassart, R. M.; Sereda, M. W.: Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease. British Medical Bulletin 102 (1), S. 89 - 113 (2012)

Goebbels, S.; Oltrogge, J.; Wolfer, S.; Wieser, G. L.; Nientiedt, T.; Pieper, A.; Ruhwedel, T.; Groszer, M.; Sereda, M. W.; Nave, K.-A.: Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. Embo Molecular Medicine 4 (6), S. 486 - 499 (2012)

Fünfschilling, U.; Supplie, L. M.; Mahad, D.; Boretius, S.; Saab, A. S.; Edgar, J. M.; Brinkmann, B. G.; Kassmann, C. M.; Tzvetanova, I.; Möbius, W. et al.; Diaz, F.; Meijer, D.; Suter, U.; Hamprecht, B.; Sereda, M. W.; Moraes, C. T.; Frahm, J.; Goebbels, S.; Nave, K.-A.: Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485 (7399), S. 517 - 521 (2012)

Makoukji, J.; Belle, M.; Meffre, D.; Stassart, R.; Grenier, J.; Shackleford, G. G.; Fledrich, R.; Fonte, C.; Branchu, J.; Goulard, M. et al.; de Waele, C.; Charbonnier, F.; Sereda, M. W.; Baulieu, E.-E.; Schumacher, M.; Bernard, S.; Massaad, C.: Lithium enhances remyelination of peripheral nerves. Proceedings of the National Academy of Sciences of the United States of America 109 (10), S. 3973 - 3978 (2012)

Fledrich, R.; Schlotter-Weigel, B.; Schnizer, T. J.; Wichert, S. P.; Stassart, R. M.; Meyer zu Hörste, G.; Klink, A.; Weiss, B. G.; Haag, U.; Walter, M. C. et al.; Rautenstrauss, B.; Paulus, W.; Rossner, M. J.; Sereda, M. W.: A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain 135 (1), S. 72 - 87 (2012)

Gess, B.; Röhr, D.; Fledrich, R.; Sereda, M. W.; Kleffner, I.; Humberg, A.; Nowitzki, J.; Strecker, J.-K.; Halfter, H.; Young, P.: Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. The Journal of Neuroscience 31 (47), S. 17180 - 17192 (2011)

Meyer zu Hoerste, G.; Miesbach, T. A.; Müller, J. I.; Fledrich, R.; Stassart, R. M.; Kieseier, B. C.; Coleman, M. P.; Sereda, M. W.: The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiology of Disease 42 (1), S. 1 - 8 (2011)

Kassmann, C. M.; Quintes, S.; Rietdorf, J.; Möbius, W.; Sereda, M. W.; Nientiedt, T.; Saher, G.; Baes, M.; Nave, K.-A.: A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity. FEBS Letters 585 (14), S. 2205 - 2211 (2011)

Leal, A.; Huehne, K.; Bauer, F.; Sticht, H.; Berger, P.; Suter, U.; Morera, B.; Del Valle, G.; Lupski, J. R.; Ekici, A. et al.; Pasutto, F.; Endele, S.; Barrantes, R.; Berghoff, C.; Neundörfer, B.; Heuss, D.; Dorn, T.; Young, P.; Santolin, L.; Uhlmann, T.; Meisterernst, M.; Sereda, M.; Meyer zu Hörste, G.; Nave, K.-A.; Reis, A.; Rautenstrauss, B.: Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 10 (4), S. 275 - 287 (2009)

Schardt, A.; Brinkmann, B. G.; Mitkovski, M.; Sereda, M. W.; Werner, H. B.; Nave, K.-A.: The SNARE protein SNAP-29 interacts with the GTPase Rab3A: Implications for membrane trafficking in myelinating glia. Journal of Neuroscience Research 87 (15), S. 3465 - 3479 (2009)

Merkler, D.; Klinker, F.; Jürgens, T.; Glaser, R.; Paulus, W.; Brinkmann, B. G.; Sereda, M. W.; Stadelmann-Nessler, C.; Guedes, R. C. A.; Brück, W. et al.; Liebetanz, D.: Propagation of spreading depression inversely correlates with cortical myelin content. Annals of Neurology 66 (3), S. 355 - 365 (2009)

Brinkmann, B. G.; Agarwal, A.; Sereda, M. W.; Garratt, A. N.; Müller, T.; Wende, H.; Stassart, R. M.; Nawaz, S.; Humml, C.; Velanac, V. et al.; Radyushkin, K.; Goebbels, S.; Fischer, T. M.; Franklin, R. J.; Lai, C.; Ehrenreich, H.; Birchmeier, C.; Schwab, M. H.; Nave, K.-A.: Neuregulin-1/ErbB Signaling Serves Distinct Functions in Myelination of the Peripheral and Central Nervous System. Neuron 59 (4), S. 581 - 595 (2008)